Literature DB >> 27636561

The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity.

Cynthia M June1, Taylor J Muckenthaler1, Emma C Schroder1, Zachary L Klamer2, Zdzislaw Wawrzak3, Rachel A Powers1, Agnieszka Szarecka2, David A Leonard1.   

Abstract

OXA-51 is a class D β-lactamase that is thought to be the native carbapenemase of Acinetobacter baumannii. Many variants of OXA-51 containing active site substitutions have been identified from A. baumannii isolates, and some of these substitutions increase hydrolytic activity toward carbapenem antibiotics. We have determined the high-resolution structures of apo OXA-51 and OXA-51 with one such substitution (I129L) with the carbapenem doripenem trapped in the active site as an acyl-intermediate. The structure shows that acyl-doripenem adopts an orientation very similar to carbapenem ligands observed in the active site of OXA-24/40 (doripenem) and OXA-23 (meropenem). In the OXA-51 variant/doripenem complex, the indole ring of W222 is oriented away from the doripenem binding site, thereby eliminating a clash that is predicted to occur in wildtype OXA-51. Similarly, in the OXA-51 variant complex, L129 adopts a different rotamer compared to I129 in wildtype OXA-51. This alternative position moves its side chain away from the hydroxyethyl moiety of doripenem and relieves another potential clash between the enzyme and carbapenem substrates. Molecular dynamics simulations of OXA-51 and OXA-51 I129L demonstrate that compared to isoleucine, a leucine at this position greatly favors a rotamer that accommodates the ligand. These results provide a molecular justification for how this substitution generates enhanced binding affinity for carbapenems, and therefore helps explain the prevalence of this substitution in clinical OXA-51 variants.
© 2016 The Protein Society.

Entities:  

Keywords:  antibiotic resistance; carbapenem; crystal structure; β-lactamase

Mesh:

Substances:

Year:  2016        PMID: 27636561      PMCID: PMC5119573          DOI: 10.1002/pro.3040

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  37 in total

1.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

Authors:  Jane F Turton; M Elaina Ward; Neil Woodford; Mary E Kaufmann; Rachel Pike; David M Livermore; Tyrone L Pitt
Journal:  FEMS Microbiol Lett       Date:  2006-05       Impact factor: 2.742

Review 2.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

3.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem.

Authors:  Kyle D Schneider; Caleb J Ortega; Nicholas A Renck; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  J Mol Biol       Date:  2011-01-06       Impact factor: 5.469

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.

Authors:  Kip-Chumba J Kaitany; Neil V Klinger; Cynthia M June; Maddison E Ramey; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

7.  Eleven novel OXA-51-like enzymes from clinical isolates of Acinetobacter baumannii.

Authors:  B A Evans; S Brown; A Hamouda; J Findlay; S G B Amyes
Journal:  Clin Microbiol Infect       Date:  2007-09-11       Impact factor: 8.067

8.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

9.  Extensively drug-resistant Acinetobacter baumannii.

Authors:  Yohei Doi; Shahid Husain; Brian A Potoski; Kenneth R McCurry; David L Paterson
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  15 in total

1.  Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase.

Authors:  Laura Dabos; Pierre Bogaerts; Remy A Bonnin; Agustin Zavala; Pierre Sacré; Bogdan I Iorga; Daniel T Huang; Youri Glupczynski; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

2.  Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.

Authors:  Juan Carlos Vázquez-Ucha; María Maneiro; Marta Martínez-Guitián; John Buynak; Christopher R Bethel; Robert A Bonomo; Germán Bou; Margarita Poza; Concepción González-Bello; Alejandro Beceiro
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  Multiple substitutions lead to increased loop flexibility and expanded specificity in Acinetobacter baumannii carbapenemase OXA-239.

Authors:  Thomas M Harper; Cynthia M June; Magdalena A Taracila; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  Biochem J       Date:  2018-01-11       Impact factor: 3.857

4.  Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase.

Authors:  Josephine P Werner; Joshua M Mitchell; Magdalena A Taracila; Robert A Bonomo; Rachel A Powers
Journal:  Protein Sci       Date:  2017-02-23       Impact factor: 6.725

5.  Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Staphylococcus aureus.

Authors:  J Andrew N Alexander; Mariia Radaeva; Dustin T King; Henry F Chambers; Artem Cherkasov; Som S Chatterjee; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

6.  Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics.

Authors:  Xingchen Bian; Xiaofen Liu; Xuefei Zhang; Xin Li; Jing Zhang; Huajun Zheng; Sichao Song; Xiang Li; Meiqing Feng
Journal:  BMC Genomics       Date:  2021-07-12       Impact factor: 3.969

7.  C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Acinetobacter baumannii Carbapenemase OXA-23 by Impeding Deacylation.

Authors:  Nichole K Stewart; Marta Toth; Maha A Alqurafi; Weirui Chai; Thu Q Nguyen; Pojun Quan; Mijoon Lee; John D Buynak; Clyde A Smith; Sergei B Vakulenko
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

8.  A New Mechanism for β-Lactamases: Class D Enzymes Degrade 1β-Methyl Carbapenems through Lactone Formation.

Authors:  Christopher T Lohans; Emma van Groesen; Kiran Kumar; Catherine L Tooke; James Spencer; Robert S Paton; Jürgen Brem; Christopher J Schofield
Journal:  Angew Chem Int Ed Engl       Date:  2018-01-05       Impact factor: 15.336

9.  Network Analysis of Protein Adaptation: Modeling the Functional Impact of Multiple Mutations.

Authors:  Violeta Beleva Guthrie; David L Masica; Andrew Fraser; Joseph Federico; Yunfan Fan; Manel Camps; Rachel Karchin
Journal:  Mol Biol Evol       Date:  2018-06-01       Impact factor: 16.240

10.  Structural Analysis of The OXA-48 Carbapenemase Bound to A "Poor" Carbapenem Substrate, Doripenem.

Authors:  Krisztina M Papp-Wallace; Vijay Kumar; Elise T Zeiser; Scott A Becka; Focco van den Akker
Journal:  Antibiotics (Basel)       Date:  2019-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.